文献速递咽喉与嗓音

光血管溶解激光治疗良性喉部病变:系统综述与Meta分析

Photoangiolytic Lasers for Treatment of Benign Laryngeal Lesions: A Systematic Review and Meta-Analysis.
PubMed 文献 · Laryngoscope · 2024-08-09

该系统综述与Meta分析检索Cochrane Library、PubMed、Scopus与CINAHL,比较445nm蓝激光、585nm脉冲染料激光(PDL)与532nm磷酸钛氧钾(KTP)激光治疗良性喉部病变的疗效,共纳入45项研究。蓝激光病变消退率最高(94.0%;95%CI 90.2%-96.7%),其次为KTP激光(90.4%;95%CI 84.1%-95.2%)与PDL(86.9%;95%CI 62.9%-99.2%);三种激光治疗后VHI-10与GRB均显著改善。作者认为光血管溶解激光治疗良性喉部病变有效,蓝激光在喉部激光手术中具有前景。

要点

  • 蓝激光病变消退率为94.0%(95%CI 90.2%-96.7%),高于KTP激光的90.4%与PDL的86.9%。
  • 蓝激光治疗后VHI-10改善Δ13.3(95%CI 10.7-16.0;p<0.0001),KTP激光Δ10.3,PDL Δ7.4,均显著。
  • 蓝激光治疗后GRB改善Δ4.1(95%CI 2.9-5.2;p<0.0001),KTP激光Δ3.0,PDL Δ2.5(p=0.005)。

核心结论

  • 光血管溶解激光治疗良性喉部病变有效;蓝激光在喉部激光手术中具有前景。

研究设计与样本

  • 遵循PRISMA指南的系统综述与Meta分析,检索Cochrane Library、PubMed、Scopus与CINAHL,检索时间自建库至2024年1月29日。
  • 共纳入45项研究,其中PDL治疗348例、KTP激光治疗550例、蓝激光治疗338例。

主要发现

  • 蓝激光病变消退率94.0%(95%CI 90.2%-96.7%),KTP激光90.4%(95%CI 84.1%-95.2%),PDL 86.9%(95%CI 62.9%-99.2%)。
  • 蓝激光治疗后VHI-10改善Δ13.3(95%CI 10.7-16.0;p<0.0001),KTP激光Δ10.3(95%CI 7.4-13.3;p<0.0001),PDL Δ7.4(95%CI 4.8-10.1;p<0.0001)。
  • 蓝激光治疗后GRB改善Δ4.1(95%CI 2.9-5.2;p<0.0001),KTP激光Δ3.0(95%CI 2.0-4.0;p<0.0001),PDL Δ2.5(95%CI 0.8-4.2;p=0.005)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare the efficacy of the 445-nm blue laser to the 585-nm pulsed dye laser (PDL) and 532-nm potassium-titanyl-phosphate (KTP) laser in the treatment of benign laryngeal lesions. DATA SOURCES: Cochrane Library, PubMed, Scopus, and CINAHL. REVIEW METHODS: Following PRISMA guidelines, databases were searched from inception through January 29, 2024, for studies reporting the use of photoangiolytic lasers for treatment of benign laryngeal lesions, including the 585-nm PDL, 532-nm KTP laser, and 445-nm blue laser. Outcome measures included lesion resolution (%), mean differences (Δ) in Voice Handicap Index (VHI-10), and summed dysphonia grade, roughness, and breathiness (GRB) scale. RESULTS: A total of 45 studies were included for meta-analysis, consisting of 348 patients treated with PDL, 550 patients with KTP laser, and 338 patients with blue laser. Treatment with blue laser resulted in the greatest lesion resolution (94.0%; 95% confidence interval [CI]: 90.2%-96.7%), followed by KTP laser (90.4%; 95% CI: 84.1%-95.2%), and PDL (86.9%; 95% CI: 62.9%-99.2%). VHI-10 improved significantly in patients following treatment with blue laser (Δ13.3; 95% CI: 10.7-16.0; p < 0.0001), KTP laser (Δ10.3; 95% CI: 7.4-13.3; p < 0.0001), and PDL (Δ7.4; 95% CI: 4.8-10.1; p < 0.0001). GRB improved significantly in patients following treatment with blue laser (Δ4.1; 95% CI: 2.9-5.2; p < 0.0001), KTP laser (Δ3.0; 95% CI: 2.0-4.0; p < 0.0001), and PDL (Δ2.5; 95% CI: 0.8-4.2; p = 0.005). CONCLUSIONS: Photoangiolytic lasers are effective in treating benign laryngeal lesions. Blue lasers are promising for laryngeal laser surgery. Laryngoscope, 134:4847-4857, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Bhat AM, Marrero-Gonzalez AR, Nguyen SA, et al. Photoangiolytic Lasers for Treatment of Benign Laryngeal Lesions: A Systematic Review and Meta-Analysis. Laryngoscope. 2024. PMID: 39119758. doi:10.1002/lary.31658

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。